Press Releases

Filter Releases
 
Press Releases
Date Title and Summary View
Jan 23, 2014
SEATTLE, Jan. 23, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the pricing of its follow-on public offering of $55 million of its common stock at a price to the public of $18.50 per share. In addition, the Company has granted th...
Jan 21, 2014
SEATTLE, Jan. 21, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced the launch of a proposed follow-on public offering of $55 million of its common stock. In addition, the Company expects to grant the underwriters a 30-day option to ...
Jan 15, 2014
SEATTLE, Jan. 15, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that it has secured an exclusive option from Massachusetts General Hospital to license intellectual property related to a novel approach for multiplexe...
Jan 13, 2014
SEATTLE, Jan. 13, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced that it has filed a registration statement with the U.S. Securities and Exchange Commission for a proposed follow-on public offering of $55 million of its common sto...
Jan 13, 2014
Approximately 55% fourth quarter and 37% full year 2013 year-over-year revenue growth anticipated Record fourth quarter instrument revenue of approximately $5.3 million, up 112% year-over-year SEATTLE, Jan. 13, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational re...
Jan 6, 2014
SEATTLE, Jan. 6, 2014 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG) today announced that its management is scheduled to participate in the JP Morgan 32nd Annual Healthcare Conference on January 15, 2014 in San Francisco. NanoString management is scheduled to present at 4:00pm PT/ 7:00 pm ET. Interested parties can access t...
Dec 18, 2013
Authors Conclude that the PAM50 Based Prosigna Assay has Achieved Level 1 Evidence, Supporting Potential Inclusion in Future Cancer Treatment Guidelines SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science tools for translational resear...
Dec 13, 2013
Prosigna Combined Analysis of TransATAC and ABCGS-8 Data Presented at the 2013 San Antonio Breast Cancer Symposium SEATTLE & SAN ANTONIO--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ:NSTG), a provider of life science tools for translational research and molecular diagnostic produc...
Dec 10, 2013
Premier Diagnostic Labs ARUP Laboratories, LabCorp, and Quest Diagnostics to Offer the Prosigna Breast Cancer Assay Conference Call to Discuss Details; Tomorrow at 8:30AM EST SEATTLE & SAN ANTONIO--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ:NSTG) a provider of l...
Nov 20, 2013
SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc. (NASDAQ: NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced the appointment of David W. Ghesquiere as Senior Vice President, Corporate & Business Development, effective immediately. ...
Nov 18, 2013
SEATTLE, Nov. 18, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG) today announced that its management is scheduled to participate in the Piper Jaffray 25th Annual Healthcare Conference on December 3, 2013 in New York. NanoString management is scheduled to present at 4:30 pm ET. Interested parties can access the live aud...
Nov 12, 2013
Multi-Mode System Available for Running the Prosigna Breast Cancer Assay,Other Multiplexed Research Assays, and Laboratory Developed Tests SEATTLE--(BUSINESS WIRE)-- NanoString Technologies, Inc., (NASDAQ: NSTG) a provider of life science tools for translational research and molecul...
Nov 5, 2013
- Strong Q3 2013 Revenue Growth of 39% - - Record Instrument Revenue of $3.6 Million, Up 63% - SEATTLE, Nov. 5, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today reported financial results for the three and nine ...
Oct 29, 2013
SEATTLE, Oct. 29, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), announced today that its management is scheduled to present at the Credit Suisse 2013 Healthcare Conference in Phoenix on Tuesday, November 12, 2013 at 8:30 am MT/ 10:30 am ET. Interested parties can access the live audio webcast for the conference at ww...
Oct 16, 2013
SEATTLE, Oct. 16, 2013 (GLOBE NEWSWIRE) -- NanoString Technologies, Inc. (Nasdaq:NSTG), a provider of life science tools for translational research and molecular diagnostic products, today announced that the company will release 2013 third quarter financial results after the close of trading on Tuesday, November 5, 2013. Company management will hos...
Page: First Previous
...
...
Next Last
 
= add release to Briefcase